We are living through an unprecedented era of new technology development in virtually all sectors of the pharmaceutical industry, most notably electronics/digital technologies, healthcare, manufacturing, consumer practices, and transportation. Ten years ago, who would have thought:
In the health sciences sector, we are witnessing transformational advances in how we treat disease. Scientists are now able to utilize viruses to genetically engineer T-cells to kill specific tumor cells, traditional batch development, and manufacturing processes are giving way to smaller footprints, much more flexible continuous and modular technologies, and something called 3-D printing is now being utilized to manufacture FDA approved drugs.
At the 2017 ISPE Annual Meeting in San Diego on 29 October – 1 November, our Innovation Forum educational track will feature seven exciting sessions that will speak to a variety of the most interesting and impactful innovative technologies in the world today, including some of the ones mentioned above. The session titles below speak to the diversity of topics included in the Innovation Forum:
Join us at some or all of the Innovation Forum sessions. You won’t be disappointed.
The 2017 ISPE Annual Meeting & Expo offers a unique experience, built to expand your professional education and increase your exposure to regulators and industry thought leaders from around the world. Education highlights include:
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...